Wockhardt Limited (NSE:WOCKPHARMA)
India · Delayed Price · Currency is INR 1,626.00
+19.50 (1.21%)
May 11, 2026, 3:29 PM IST
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 261.04 billion as of May 11, 2026. Its market cap has increased by 14.64% in one year.
Market Cap
261.04B
Enterprise Value
280.16B
Revenue
34.84B
Ranking
n/a
PE Ratio
122.63
Stock Price
1,626.00
Market Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 261.04B, an increase of 1,399.93%. That is a compound annual growth rate of 11.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 264.15B | 12.40% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 393.90B |
| Ajanta Pharma | 379.03B |
| Gland Pharma | 313.76B |
| Emcure Pharmaceuticals | 311.50B |
| Piramal Pharma | 238.81B |
| NATCO Pharma | 210.40B |
| Eris Lifesciences | 192.03B |
| Cohance Lifesciences | 186.77B |